Person:

Kazlauskas, Andrius

Loading...
Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Kazlauskas

First Name

Andrius

Name

Kazlauskas, Andrius

Search Results

Now showing 1 - 2 of 2
  • Publication

    Dual-Modality Fluorescence and Full-Field Optical Coherence Microscopy for Biomedical Imaging Applications

    (Optical Society of America, 2012) Auksorius, Egidijus; Bromberg, Yaron; Motiejūnaitė, Rūta; Pieretti, Alberto; Liu, Linbo; Coron, Emmanuel; Aranda, Jorge; Goldstein, Allan; Bouma, Brett; Kazlauskas, Andrius; Tearney, Guillermo

    Full-field optical coherence microscopy (FFOCM) is a high-resolution interferometric technique that is particularly attractive for biomedical imaging. Here we show that combining it with structured illumination fluorescence microscopy on one platform can increase its versatility since it enables co-localized registration of optically sectioned reflectance and fluorescence images. To demonstrate the potential of this dual modality, a fixed and labeled mouse retina was imaged. Results showed that both techniques can provide complementary information and therefore the system could potentially be useful for biomedical imaging applications.

  • Publication

    Diabetes Disrupts the Response of Retinal Endothelial Cells to the Angiomodulator Lysophosphatidic Acid

    (American Diabetes Association, 2012) Aranda, Jorge; Motiejunaite, Ruta; Im, Eunok; Kazlauskas, Andrius

    The objectives of this study were to investigate how diabetes mellitus (DM) influences responsiveness of retinal neovessels to lysophosphatidic acid (LPA) and to elucidate the underlying mechanism. To this end, we used an ex vivo assay in which neovessels sprouted from retinal explants (isolated from either control or DM mice) when cultured between two layers of collagen and in the presence of vascular endothelial growth factor-A. While DM had no effect on the formation of neovessels, it prevented LPA-induced regression. High-glucose (HG) treatment of retinal explants mimicked the DM phenotype. Similarly, primary retinal endothelial cells (RECs), which were subjected to HG treatment, organized into tubes that were resistant to LPA. HG caused LPA resistance within RECs by elevating ROS, which activated Src-family kinases that stimulated the extracellular signal–related kinase (Erk) pathway, which antagonized LPA-mediated signaling events that were required for regression. This ROS/Src/Erk pathway mechanism appeared to be the same route by which DM induced LPA resistance of retinal neovessels. We conclude that DM/HG reprograms signaling pathways in RECs to induce a state of LPA resistance.